NIH Names Leadership, Research Units for Restructured HIV/AIDS Clinical Trials Networks

NIH Names Leadership, Research Units for Restructured HIV/AIDS Clinical Trials Networks

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases

Visit us on the Web

NIH Names Leadership, Research Units for Restructured HIV/AIDS Clinical Trials Networks

NIAID has selected the principal investigators and clinical trials units (CTUs) that will lead and conduct the research of the five restructured HIV/AIDS clinical trials networks through 2021. The new structure is designed to create a broader, more flexible and more collaborative approach to the networks’ research priorities, which include therapeutics, HIV-associated infections, prevention strategies, vaccines and microbicides. Total funding for the networks’ leadership and the CTUs is expected to reach $225 million in 2014, the first year of operation.

For more information and a list of the principal investigators and leadership groups, visit:http://www.niaid.nih.gov/news/newsreleases/2013/Pages/clinical-trials-network.aspx.

For a list of the CTUs and affiliated clinical research sites, visit: http://www.niaid.nih.gov/news/newsreleases/2013/Pages/Table.aspx.